Penmesterol
Appearance
This section may contain an excessive number of citations. (December 2024) |
Clinical data | |
---|---|
Trade names | Pandocrine; Testopan |
Other names | RP-12222; 17α-Methyltestosterone 3-cyclopentyl enol ether |
Routes of administration | By mouth |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.000.609 |
Chemical and physical data | |
Formula | C25H38O2 |
Molar mass | 370.577 g·mol−1 |
3D model (JSmol) | |
| |
|
Penmesterol (INN ) (brand names Pandrocine, Testopan; former developmental code name RP-12222), or penmestrol, also known as 17α-methyltestosterone 3-cyclopentyl enol ether,[1] is a synthetic, orally active anabolic-androgenic steroid (AAS) that was developed in the early 1960s.[2][3][4][5] It is the 3-cyclopentyl enol ether of methyltestosterone.[6][7]
See also
[edit]References
[edit]- ^ Negwer M, Scharnow HG (4 October 2001). Organic-chemical drugs and their synonyms: (an international survey). Wiley-VCH. p. 2653. ISBN 978-3-527-30247-5.
- ^ Elks J (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 942–. ISBN 978-1-4757-2085-3.
- ^ Azziz R (8 November 2007). Androgen Excess Disorders in Women. Springer Science & Business Media. pp. 122–. ISBN 978-1-59745-179-6.
- ^ Sittig M, William Andrew Publishing (22 October 2013). Pharmaceutical Manufacturing Encyclopedia, 3rd Edition. Elsevier. pp. 2935–. ISBN 978-0-8155-1856-3.
- ^ List PH, Hörhammer L (12 March 2013). Chemikalien und Drogen Teil A: N-Q. Springer-Verlag. pp. 504–. ISBN 978-3-642-65035-2.
- ^ Ercoli A, Gardi R (1960). "Δ4-3-Keto Steroidal Enol Ethers. Paradoxical Dependency of Their Effectiveness on the Administration Route". Journal of the American Chemical Society. 82 (3): 746–748. Bibcode:1960JAChS..82..746E. doi:10.1021/ja01488a062.
- ^ Wermuth CG (2 May 2011). The Practice of Medicinal Chemistry. Academic Press. pp. 731–. ISBN 978-0-08-056877-5.